| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |